Articles On Creso Pharma (ASX:CPH)

ASX investors who took a bet on meme stocks experienced vastly differing returns but which stock they chose wasn’t the only factor determining how they went. Research by Openmarkets group covering 11 “ASX meme stocks” found that investors o...

Retail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired for testing positive for marijuana to reapply for jobs. The company has now excluded marijuana from its comprehensive pre-employment drug scr...

Creso Pharma’s subsidiary, Halucenex Life Sciences Inc and Acadia aim for the formulation to have a quick release effect, good bioavailability of the active ingredients and rapid action.

The Little Green Pharma Ltd (ASX: LGP) share price has had a tough run over the past few months. This comes despite the medicinal cannabis producer releasing some positive announcements to the market of late. At Friday’s closing bell, Litt...

The Creso Pharma Ltd (ASX: CPH) share price edged higher during morning trade after the company announced the launch of new e-commerce channels and its first purchase order from Poland. The Creso share price rose by more than 8% above yest...

Leader of the ASX health stocks today is Imugene (ASX:IMU) up 4.11% after announcing plans to present its PD1-Vaxx cancer checkpoint immunotherapy program at the ESMO Congress 2021 Annual Meeting in Paris. The company says clinical results...

Ahead of favourable regulatory changes in the US, the cannabinoid therapy developer hopes the dual listing will expedite growth and unlock value for existing Australian and new US shareholders. 

The Creso Pharma Ltd (ASX: CPH) share price is on the move today, reversing yesterday’s losses. This comes as the cannabis and psychedelics company released a positive update to the ASX on Monday. During morning trade, Creso shares are swa...

While CPH has signed several purchase orders over the last 12 months, this PO represents an important milestone for the company, as it underpins the company’s geographic expansion regarding its human health business.

The purchase orders received today will open the door for additional purchase orders for Creso Pharma, including its animal health products. Global medicinal cannabis company, Creso Pharma (ASX:CPH), has expanded its presence in Europe afte...

The Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused drinks in Canada with the help of Australian listed Althea Group Holdings’ (ASX:AGH) subsidiary. Peak processing Solutions will research and d...

Leader of the pot stocks today is Roto-Gro International (ASX:RGI), which rose 6.45% in morning trade. It followed news that RGI customer Canniberia has been granted pre-approval for its cannabis cultivation license from Infarmed I.P – a go...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Top of the ASX health stocks today is Creso Pharma (ASX:CPH), which rose more than 10% after announcing plans to pursue a NASDAQ and ASX dual listing. The news follows a mutual termination of its proposed merger with Red Light Holland Corp....

The Creso Pharma Ltd (ASX: CPH) share price has been among the best performers on Tuesday. At the time of writing, the cannabis and psychedelics company’s shares are up 16% to 14 cents. Why is the Creso Pharma share price rocketing higher?...

Australian cannabis company Creso Pharma (ASX: CPH) today has announced it will pursue a dual listing on the NASDAQ and ASX following the mutual termination of a proposed merger with psychedelics company Red Light Holland. In an ASX statem...

Virginia is the latest US state to legalise marijuana and they’re celebrating with the first annual CannaFest VA cannabis trade show on September 19. The event will feature a concert, and a custom car and motorcycle exhibition but no, you c...

ASX cannabis shares put in a mixed performance in the 2021 financial year (FY21). Of the 9 stocks broadly falling into the ‘ASX cannabis share’ category, 6 saw their share prices fall while 3 gained in FY21. Creso Pharma Ltd (ASX: CPH) was...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The Creso Pharma Ltd (ASX: CPH) share price isn’t going anywhere on Thursday. This comes after the cannabis and psychedelics company requested a trading halt in the minutes during market open. As such, Creso Pharma shares are frozen at 13...

Massachusetts based cannabis operator MariMed has just announced a joint collaboration with the legendary Boston ice cream brand Emack & Bolio’s® to create a line-up of cannabis-infused vegan and dairy ice cream. The ice cream will cont...

Aussie pot stock Creso Pharma [ASX:CPH] shares is on the up today. The share price is currently trading 8% higher at time of writing. Climbing on the back of some positive news from one of Creso’s Canadian subsidiaries. The post Creso Pharm...

Aussie pot stock Creso Pharma [ASX:CPH] share price is on the up today. The share price is currently trading 8% higher at time of writing. The post Creso Pharma Secures New Win in Canada — Shares Up 8% (ASX:CPH) appeared first on Money Mo...

The Creso Pharma Ltd (ASX: CPH) share price is having a fantastic day on the ASX. The company’s shares are soaring after it announced its subsidiary, Mernova, has been granted a medical cannabis licence in Canada. Mernova has also received...

The new licence will take Mernova and Creso Pharma into the huge medicinal cannabis market in Canada, with the potential to unlock the recurring revenue model. In a major development, global medicinal cannabis company, Creso Pharma (ASX:CPH...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

The Creso Pharma Ltd (ASX: CPH) share price has climbed well into the green in early trade today. Cresco Pharma shares are now exchanging hands at 11.75 cents apiece, an almost 7% gain from the open. What is Creso Pharma? Creso Pharma de...

The Creso Pharma Ltd [ASX:CPH] share price is up 9% after the release of its June quarter results. The CPH share price were trading for 12 cents at time of writing... The post Creso Share Price Surges 9% on June Quarter Results (ASX:CPH) a...

Local markets have made a strong start to the week, with the ASX200 closing 1.34% higher on Monday as some major M&A activity stole the headlines. Gains were led by the tech sector, as Afterpay (ASX:APT) showed its weight by dragging th...

Creso Pharmaceuticals (ASX:CPH) jumped 9.09% today off the back of a strong quarterly detailing an 18% revenue increase on previous period to $1,633,000 and a whopping 451% increase on the previous year. The company’s cannabis cultivation a...

The Creso Pharma Ltd (ASX: CPH) share price is soaring this morning, trading 9% higher at 12 cents apiece at time of writing. Below, we take a look at the ASX cannabis share’s quarterly results for the period ending 30 June (Q2) What quart...

Wall Street weakens, Square to acquire Afterpay All three US benchmarks fell on Friday, as earnings results kept coming in. The Dow Jones fell bty 0.42%, S&P 500 by 0.54%, and tech heavy Nasdaq by 0.71%. Amazon fell shorts of analysts’...

The Community College of Denver (CCD) has just launched a cannabis business program in Colorado. The new program offers students the opportunity to earn an Associate of Applied Science degree designed to prepare them to become business mana...

Australia has the potential to become the international gold standard for production of medicinal marijuana and multiple ASX-listed companies are seeking to benefit. -Manufacturing of medicinal cannabis products has been legal in Australia...

Pot stock Creso Pharma [ASX:CPH] is on the up today. Shares are trading 1.54% higher as the company announced some new developments from its Canadian subsidiary: Halucenex. The post Creso Pharma Shares on the Rise as Its Subsidiary Announce...

Pot stock Creso Pharma [ASX:CPH] is on the up today. Shares are trading 1.54% higher as the company announced some new developments from its Canadian subsidiary: Halucenex... The post Creso Share Price Up as Its Subsidiary Announces New MOU...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Aussie pot stock Creso Pharma [ASX:CPH] shares are on the up today. Shares are trading 8.89% higher on the news of the launch of Creso’s newest drug, cannaDOL. The post Creso Pharma Launches New Cannabis Drug — Shares Rise 8.9% appeared fir...

Aussie pot stock Creso Pharma Ltd [ASX:CPH] shares are on the up today. The CPH Share Price is trading 8.89% higher on the news of the launch of Creso’s newest drug, cannaDOL... The post Creso Share Price Up — Launches New Cannabis Drug (A...

Creso Pharma (ASX:CPH) is applauding breakthrough legislation by Democratic leaders in the US Senate to legalise marijuana at the federal level, as reform efforts in the United States gain steam. To be sure, the proposal by Senate Majority...

This week Technicorum Holdings announced an upcoming token sale and launch of The CanCoin – a cannabis token designed to solve market friction and monetisation in the European cannabis market and to help build blockchain-based solutions for...

The Creso Pharma [ASX:CPH] share price jumped 8% after completing the acquisition of Canadian psychedelics company Halucenex Life Sciences. The post CPH Share Price Up on Completed Halucenex Acquisition (ASX:CPH) appeared first on Money Mor...

The Creso Pharma Ltd (ASX: CPH) share price has been a very strong performer on Thursday. In early trade, the cannabis and psychedelics company’s shares are up 15% to 15 cents. Why is the Creso share price surging higher? Investors have be...

Trading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers and other famous investors over the last fortnight. Specifically, Stockhead tracks substantial shareholder movements, being shareholders hold...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

The 2021 financial year was overall a very good one for ASX shares. The S&P/ASX 200 Index (ASX: XJO) managed to put on a performance of 24% for the 12 months to 30 June 2021. That makes FY2021 one of the best financial years ever for t...

In a development that highlights the substantial benefits of a proposed merger between Creso Pharma Limited (ASX:CPH, FRA:1X8) and Red Light Holland, the former has secured its first purchase order from Red Light Holland’s wholly-owned dist...

The purchase order received by Creso Pharma from Red Light Holland marks an important first step towards the creation of the HighBrid Lab. Global medicinal cannabis company, Creso Pharma (ASX:CPH), has landed its first sale in the Netherlan...

Cannabis stocks have welcomed the change in ownership of Pershing Australia from Bank of New York Mellon (BNYM) to Finclear Pty Ltd which – effective immediately – will allow the trading of cannabis securities on the ASX. In late 2019, BNYM...

Creso Pharma Ltd (ASX:CPH | OTC:COPHF) has just confirmed two consecutive quarters of record revenue growth. CPH posted $1.71M revenue this quarter - up from $1.38M in the previous quarter - that’s 24% growth.